V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330002297 | 330006681 | null | 54 | Palliative (P) | 2014-12-10 | 2015-01-05 | Liposomal Doxorubicin (20mg/m2) | null | N | 330008497 | LIPOSOMAL DOXORUBICIN |
| 330002298 | 330006681 | 1.72 | null | Palliative (P) | 2015-09-17 | 2015-09-22 | DOXORUBICIN | 02 | N | 330008497 | DOXORUBICIN |
| 330002299 | 330006681 | 1.61 | 7.6 | Palliative (P) | 2015-02-07 | 2015-02-18 | Carboplatin + Etoposide IV 3 day | 2 | N | 330008497 | CARBOPLATIN + ETOPOSIDE |
| 330002300 | 330001296 | 1.64 | 85.8 | Palliative (P) | 2018-08-11 | 2018-08-11 | Rituximab | N | N | 330008521 | RITUXIMAB |
| 330002301 | 330001297 | 1.75 | 102.9 | null | 2016-08-25 | 2016-08-25 | CARBOPLATIN + PACLITAXEL | 2 | null | 330008525 | CARBOPLATIN + PACLITAXEL |
| 330002302 | 330006682 | 1.65 | 0 | Not known (9) | 2016-08-21 | 2016-08-22 | Rituximab | N | N | 330008536 | RITUXIMAB |
| 330002303 | 330006682 | 1.8 | null | Palliative (P) | 2016-02-02 | 2016-02-02 | Carboplatin 21day + Paclitaxel 7day | N | N | 330008536 | CARBOPLATIN + PACLITAXEL |
| 330002307 | 330001299 | 1.62 | 80.5 | Neo-adjuvant (N) | 2015-10-30 | 2015-11-17 | CNS GCT II Germinoma - Carbo Etop | N | Y | 330008558 | CARBOPLATIN + ETOPOSIDE |
| 330002308 | 330001299 | 1.9 | 71 | Palliative (P) | 2013-12-19 | 2013-12-22 | Liposomal Doxorubicin (Caelyx) | N | N | 330008558 | LIPOSOMAL DOXORUBICIN |
| 330002309 | 330001299 | 1.83 | 0 | Palliative (P) | null | 2017-07-13 | DOXORUBICIN | null | null | 330008558 | DOXORUBICIN |
| 330002310 | 330001300 | 1.71 | 69.9 | Curative (C) | 2015-03-08 | 2015-03-22 | Carboplatin + Etoposide iv&po | 02 | Y | 330008567 | CARBOPLATIN + ETOPOSIDE |
| 330002311 | 330001301 | 1.74 | 57.1 | Palliative (P) | null | 2016-07-04 | Carboplatin + Etoposide iv&po | N | N | 330008570 | CARBOPLATIN + ETOPOSIDE |
| 330002313 | 330001303 | 1.84 | 58.5 | Palliative (P) | 2015-05-21 | 2015-06-07 | Cisplatin + Doxorubicin | 02 | N | 330008572 | CISPLATIN + DOXORUBICIN |
| 330002314 | 330001304 | 1.57 | 60.4 | Palliative (P) | 2015-12-04 | 2015-12-10 | Carboplatin + Etoposide IV 3 day | null | null | 330008582 | CARBOPLATIN + ETOPOSIDE |
| 330002315 | 330001305 | 1.73 | 105.3 | Disease modification (D) | 2013-12-10 | 2013-12-17 | Rituximab | 2 | N | 330008583 | RITUXIMAB |
| 330002316 | 330001305 | null | 78.2 | Curative (C) | 2015-04-04 | 2015-04-04 | CARBOPLATIN | N | N | 330008583 | CARBOPLATIN |
| 330002317 | 330001306 | 1.64 | 77 | Curative (C) | null | 2016-12-27 | Carboplatin + Etoposide iv&po | N | N | 330008592 | CARBOPLATIN + ETOPOSIDE |
| 330002318 | 330001307 | 1.68 | 50 | Neo-adjuvant (N) | 2016-01-29 | 2016-01-31 | CARBOPLATIN + ETOPOSIDE | 2 | N | 330008594 | CARBOPLATIN + ETOPOSIDE |
| 330002319 | 330001308 | 1.88 | 83.5 | Curative (C) | 2017-03-02 | 2017-04-01 | Liposomal Doxorubicin (20mg/m2) | N | N | 330008603 | LIPOSOMAL DOXORUBICIN |
| 330002320 | 330001308 | 1.72 | 78 | null | 2016-12-12 | 2016-12-18 | DOXORUBICIN | 02 | N | 330008603 | DOXORUBICIN |
| 330002321 | 330001309 | 1.86 | 65.95 | Curative (C) | 2013-06-19 | 2013-06-19 | CARBOPLATIN | 02 | N | 330008611 | CARBOPLATIN |
| 330002322 | 330001310 | 1.5 | 91.8 | Curative (C) | 2015-06-30 | 2015-07-02 | CARBOPLATIN | null | null | 330008614 | CARBOPLATIN |
| 330002323 | 330001310 | 1.61 | 98 | Palliative (P) | 2013-10-13 | 2013-11-03 | DOXORUBICIN | N | N | 330008614 | DOXORUBICIN |
| 330002324 | 330001310 | 1.52 | 63 | Palliative (P) | 2013-07-23 | 2013-07-23 | Doxorubicin 75mg/m2 | 02 | N | 330008614 | DOXORUBICIN |
| 330002325 | 330011215 | 1.61 | 85 | null | 2017-12-26 | 2018-01-07 | Doxorubicin 75mg/m2 | N | N | 330008637 | DOXORUBICIN |
| 330002326 | 330001311 | 1.55 | 65.8 | Neo-adjuvant (N) | 2013-02-26 | 2013-03-06 | Carboplatin + Etoposide IV 3 day | 2 | null | 330008639 | CARBOPLATIN + ETOPOSIDE |
| 330002327 | 330001311 | 1.7 | 88.3 | Curative (C) | 2013-02-15 | 2013-02-15 | Liposomal Doxorubicin (20mg/m2) | 2 | N | 330008639 | LIPOSOMAL DOXORUBICIN |
| 330002330 | 330006689 | 1.61 | 69.6 | Adjuvant (A) | 2016-03-29 | 2016-04-04 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 330008651 | CARBOPLATIN + PACLITAXEL |
| 330002331 | 330006689 | 1.41 | 61.9 | Adjuvant (A) | 2014-04-22 | 2014-04-27 | CARBOPLATIN | N | N | 330008651 | CARBOPLATIN |
| 330002332 | 330006689 | 1.72 | 78 | Adjuvant (A) | 2013-11-09 | 2013-11-09 | Cisplatin + Doxorubicin | 2 | null | 330008651 | CISPLATIN + DOXORUBICIN |
| 330002334 | 330001315 | 1.7 | 8.3 | Palliative (P) | 2013-12-20 | 2013-12-31 | Carboplatin AUC 2 - 5 | N | N | 330008679 | CARBOPLATIN |
| 330002335 | 330001315 | 1.72 | 84 | Disease modification (D) | 2017-10-13 | 2017-10-13 | Rituximab | 2 | null | 330008679 | RITUXIMAB |
| 330002336 | 330001315 | 1.69 | 62 | Palliative (P) | 2015-02-21 | 2015-03-06 | Doxorubicin 75mg/m2 | N | N | 330008679 | DOXORUBICIN |
| 330002337 | 330001315 | 1.7 | 65.3 | Disease modification (D) | 2014-12-07 | 2014-12-07 | Rituximab | 02 | N | 330008679 | RITUXIMAB |
| 330002338 | 330001315 | 1.7 | 53 | null | 2014-03-14 | 2014-06-22 | BENDAMUSTINE + RITUXIMAB | 02 | N | 330008679 | BENDAMUSTINE + RITUXIMAB |
| 330002339 | 330001316 | null | 58.5 | Palliative (P) | 2014-02-13 | 2014-03-07 | DOXORUBICIN | 02 | N | 330008704 | DOXORUBICIN |
| 330002340 | 330001316 | 1.7 | 68.6 | Palliative (P) | 2018-04-01 | 2018-04-09 | BENDAMUSTINE + RITUXIMAB | 02 | N | 330008704 | BENDAMUSTINE + RITUXIMAB |
| 330002341 | 330009611 | null | 82 | Curative (C) | 2015-09-10 | 2015-09-17 | Liposomal Doxorubicin (Caelyx) | null | N | 330008713 | LIPOSOMAL DOXORUBICIN |
| 330002342 | 330001317 | null | 67 | Curative (C) | 2015-12-14 | 2015-12-14 | Carboplatin + Etoposide IV 3 day | null | N | 330008719 | CARBOPLATIN + ETOPOSIDE |
| 330002343 | 330001317 | 1.7 | 58 | Disease modification (D) | 2016-04-06 | 2016-04-06 | Carboplatin AUC 6 - 10 | 02 | null | 330008719 | CARBOPLATIN |
| 330002344 | 330001317 | 1.67 | 76.6 | Palliative (P) | 2017-04-13 | 2017-05-06 | BENDAMUSTINE + RITUXIMAB | N | N | 330008719 | BENDAMUSTINE + RITUXIMAB |
| 330002345 | 330001318 | null | 77 | Neo-adjuvant (N) | 2014-04-20 | 2014-04-29 | CARBOPLATIN + PACLITAXEL | N | null | 330008723 | CARBOPLATIN + PACLITAXEL |
| 330002346 | 330001318 | 1.81 | 76 | Disease modification (D) | 2015-07-13 | 2015-08-02 | Bendamustine+Rituximab (1st Course) | N | N | 330008723 | BENDAMUSTINE + RITUXIMAB |
| 330002347 | 330001319 | 1.7 | 50.7 | Neo-adjuvant (N) | 2015-10-19 | 2015-10-26 | Cisplatin + Doxorubicin | 02 | N | 330008733 | CISPLATIN + DOXORUBICIN |
| 330002348 | 330001319 | 1.76 | 90 | Curative (C) | 2014-10-12 | 2015-08-03 | CARBOPLATIN | 02 | N | 330008733 | CARBOPLATIN |
| 330002349 | 330001320 | 1.81 | 58.6 | Palliative (P) | null | 2013-09-24 | Doxorubicin 75mg/m2 | N | N | 330008739 | DOXORUBICIN |
| 330002350 | 330001320 | 1.62 | 8.3 | Adjuvant (A) | 2017-03-14 | 2017-03-18 | Doxorubicin 75mg/m2 | 2 | N | 330008739 | DOXORUBICIN |
| 330002351 | 330001320 | 0 | 73.7 | Neo-adjuvant (N) | null | 2013-07-12 | Carboplatin + Paclitaxel (weekly) | null | null | 330008739 | CARBOPLATIN + PACLITAXEL |
| 330002352 | 330001320 | 1.6 | 66 | Palliative (P) | 2015-04-19 | 2015-04-21 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 330008739 | CARBOPLATIN + PACLITAXEL |
| 330002353 | 330001320 | null | 75 | null | 2016-06-13 | 2016-07-02 | BENDAMUSTINE + RITUXIMAB | N | N | 330008739 | BENDAMUSTINE + RITUXIMAB |